Schor Chen 4

What Happened

• Schor Chen, President & CEO and a director of Adicet Bio (ACET), had 1,755 shares withheld by the company on January 24, 2026 to satisfy tax withholding obligations related to the vesting of restricted stock units (RSUs). The shares were valued at $8.44 each, totaling approximately $14,812.
• This was a tax-withholding action (transaction code F), not an open-market sale by the reporting person.

Key Details

• Transaction date and price: January 24, 2026 — 1,755 shares withheld at $8.44 per share (≈ $14,812 total).
• Transaction type: F (shares withheld to satisfy tax withholding on RSU vesting).
• Shares owned after transaction: Not specified in the provided filing excerpt; see the full Form 4 for total beneficial ownership.
• Footnotes:
  • F1: Shares were withheld by the issuer to satisfy tax withholding on RSU vesting and do not represent a sale by the reporting person.
  • F2: Reflects a 1-for-16 reverse stock split effected December 30, 2025.
  • F3/F4: Certain shares are held by The I. Schor IRRV Trust and The C. Schor IRRV Trust (irrevocable family trusts with independent trustees).
• Filing timeliness: Report filed Jan 27, 2026 for a Jan 24, 2026 event — appears to be timely.

Context

• Withholding shares to cover taxes on vested RSUs is a routine administrative action and is not the same as the insider selling shares on the open market; it generally should not be interpreted as a personal liquidity-driven sale signal.
• The reverse 1-for-16 split noted in the filing adjusts historic share counts; check pre- and post-split figures when comparing past filings.